ReviewNaunyn-Schmiedeberg's archives of pharmacology2026
Insights into dietary supplements as popular product supporting the diet.
Review in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Changing lifestyles and the rising incidence of lifestyle diseases are causing people to increasingly turn to dietary supplements, often perceived as therapeutic measures aimed at maintaining or improving health. Although supplements cannot be marketed for the treatment or prevention of disease, many people assume they will improve health, alleviate the course of illness, or, for example, delay the aging process. Unfortunately, this is not true. Furthermore, people around the world often choose to treat illnesses with supplements instead of consulting with specialists and undergoing appropriate treatment. Information on supplement safety and some common interactions with drugs and food was gathered based on an analysis of numerous websites, databases, and publications. This analysis presents statistical data, current legal regulations, the advantages and disadvantages of supplementation, and highlights the importance of supplement control. It turns out that manufacturers are generally exempt from conducting costly and lengthy clinical trials by classifying their products as dietary supplements. This misinformation prevents consumers from making informed decisions about their use. Educating the public about the safety, benefits, and risks of dietary supplements is crucial. These topics should serve as a starting point for a broader discussion about the need for quality control and access to safe dietary supplements. Raising public awareness of healthcare in its broadest sense is crucial.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.